Skip to main content
SpringerLink
Log in

Relationship between anemia, fatigue, and quality of life in cancer patients

  • Chapter
Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

Abstract

Anemia is a common cause of morbidity among patients with malignancies, especially in those receiving aggressive chemotherapy and in patients with advanced stages of cancer (Groopman and Itri 2000; Khayat 2000). The clinical symptoms of anemia, such as fatigue, dyspnoea, vertigo, loss of appetite, and inability to concentrate impair the patients physical functioning and subjective sense of well-being (Groopman and Itri 2000). By relieving these symptoms, effective treatment of anemia should significantly help to maintain patients’ quality of life (QoL) and also to improve the possibility to complete the antitumor therapy as intended.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aaronson NK (1991) Methodological issues in assessing the quality of life of cancer patients. Cancer 67: 844–850

    Article  PubMed  CAS  Google Scholar 

  • Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376

    Article  PubMed  CAS  Google Scholar 

  • Aaronson NK, Cull A, Kaasa S et al (1994) The European Organization for Research and Treatment of Cancer ( EORTC) modular approach to quality of life assessment in oncology. Int J Ment Health 23: 75–96

    Google Scholar 

  • Abels RI, Larholt KM, Krantz KD, Bryant EC (1996) Recombinant human erythropoietin (rHuEPO) for the treatment of anemia in cancer. Oncologist 1: 140–150

    PubMed  CAS  Google Scholar 

  • Andersson RT, Aaronson NK, Willen D (1993) Critical review of the international assessments of health-related quality of life. Quality of Life Res 2: 369–395

    Article  Google Scholar 

  • Case DC, Bukowski RM, Carey RW et al (1993) Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. J Natl Cancer Inst 85: 801–806

    Article  PubMed  Google Scholar 

  • Cella DF (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34 (Suppl 2): 13–19

    PubMed  CAS  Google Scholar 

  • Cella DF, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 11: 570–579

    PubMed  CAS  Google Scholar 

  • Cleeland CS, Demetri GD, Glaspy J et al (1999) Identifying hemoglobin level for optimal quality of life: results of an incremental analysis. [Abstr] Proc Am Soc Clin Oncol 18: 574a

    Google Scholar 

  • Cull AM (1997) Cancer-specific quality of life questionnaires: The state of the art in Europe. Eur J Cancer 33 (Suppl 6): S3 - S7

    Article  PubMed  Google Scholar 

  • Demetri GD, Kris M, Wade J et al (1998) Quality of life benefit in chemotherapy patients treated with epoetin alpha is independent of disease response and tumor type: results from a prospective community oncology study. J Clin Oncol 16: 3412–3425

    PubMed  CAS  Google Scholar 

  • Glaspy J, Bukowski R, Steinberg D et al (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15: 1218–1234

    PubMed  CAS  Google Scholar 

  • Glimelius B, LinnĂ© T, Hoffman K et al (1998) Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. J Clin Oncol 16: 43–40

    Google Scholar 

  • Groopman JE, Itri JE (2000) Chemotherapy induced anemia in adults: Incidence and treatment. J Natl Cancer Inst 91: 1616–1634

    Google Scholar 

  • de Haes H, Curran D, Young T et al (2000) Quality of life evaluation in clinical trials — the EORTC model. Eur J Cancer 36: 821–825

    Article  PubMed  Google Scholar 

  • Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L (1994) The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. Cancer Nurs 17: 367–378

    Article  PubMed  CAS  Google Scholar 

  • Khayat D (2000) Is anemia a problem for European cancer patients and treating oncologists? Semin Oncol 27 (Suppl 4): 9–11

    PubMed  CAS  Google Scholar 

  • Kurz C, Marth C, Windbichler G et al (1997) Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study. Gynecol Oncol 65: 461–466

    Article  PubMed  CAS  Google Scholar 

  • Langer CJ (1997) Anemia, fatigue and quality of life in advanced malignancy: Potential therapeutic role for epoetin. Erythropoiesis: New dimensions in the treatment of anemia 8: 63–73

    Google Scholar 

  • Leitgeb C, Pecherstorfer M, Fritz E, Ludwig H (1994) Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 73: 2535–2542

    Article  PubMed  CAS  Google Scholar 

  • Littlewood TJ, Bajetta E, Nortier J et al (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19: 2865–2874

    PubMed  CAS  Google Scholar 

  • Ludwig H, Fritz E, Leitgeb C et al (1993) Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Ann Oncol 4: 161–167

    PubMed  CAS  Google Scholar 

  • Richardson A (1995) Fatigue in cancer patients: a review of the literature. Eur J Cancer Care 4: 20–32

    Article  CAS  Google Scholar 

  • Thatcher N, De Campos ES, Bell DR et al (1999) Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer 80: 396–402

    Article  PubMed  CAS  Google Scholar 

  • Vogelzang NJ, Breitbart W, Cella D et al (1997) Patient, caregiver and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. Semin Hematol 34 (Suppl 2): 4–12

    PubMed  CAS  Google Scholar 

  • Yellen SB, Cella DF, Webster K et al (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy ( FACT) measurement system. J Pain Symptom Manage 13: 63–74

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Karolinska Hospital, S-171 76, Stockholm, Sweden

    Yvonne Brandberg

Authors
  1. Yvonne Brandberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yvonne Brandberg .

Editor information

Editors and Affiliations

  1. Innere Klinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, Universitätsklinikum, Essen, Deutschland

    M. R. Nowrousian

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag/Wien

About this chapter

Cite this chapter

Brandberg, Y. (2002). Relationship between anemia, fatigue, and quality of life in cancer patients. In: Nowrousian, M.R. (eds) Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7658-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-7658-0_9

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-7660-3

  • Online ISBN: 978-3-7091-7658-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation